Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

AR polyglycine repeat doesn't cause baldness.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Right hand finger ratio may predict male hair loss.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Combination therapy with higher concentrations of minoxidil can lead to rapid hair growth in pattern baldness with no significant side effects.

Gene variation affects prostate issues and hair loss.

Shorter GGN repeats in the androgen receptor gene are linked to androgenetic alopecia.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Higher DHT in male baldness may protect against prostate cancer.

Men with enlarged prostates often have more severe baldness.

High DHEA-S levels may cause hair loss in young men.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Two treatments for male pattern hair loss are minoxidil and finasteride, but they have side effects and may not satisfy everyone.

Minoxidil, finasteride, and low-level laser light therapy effectively treat hair loss.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Genetics and hormones cause hair loss; finasteride treats it safely.

Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Stopping minoxidil treatment resumes balding; continuous use needed for results.

A gene called HDAC9 might be a new factor in male-pattern baldness.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.